Age
Item
must be ≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
Prostate carcinoma
Item
confirmed and documented diagnosis of prostate cancer
boolean
C0600139 (UMLS CUI [1])
Disease Progression Evidence of | Hormone refractory prostate cancer
Item
confirmed and documented evidence of progression of disease (hormone refractory)
boolean
C0242656 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C1328504 (UMLS CUI [2])
Low testosterone levels
Item
low testosterone levels
boolean
C4011625 (UMLS CUI [1])
Chemotherapy naive
Item
chemotherapy-naïve
boolean
C0392920 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Therapeutic radiology procedure
Item
recent radiation therapy (within 4 weeks)
boolean
C1522449 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
known brain metastasis
boolean
C0220650 (UMLS CUI [1])
Peripheral Neuropathy
Item
peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
Diarrhea
Item
active diarrhea
boolean
C0011991 (UMLS CUI [1])
Illness | Heart Disease | Diabetes Mellitus | Communicable Diseases chronic | Communicable Diseases Uncontrolled
Item
significant illnesses such as heart disease, diabetes, or chronic or uncontrolled infections
boolean
C0221423 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0011849 (UMLS CUI [3])
C0009450 (UMLS CUI [4,1])
C0205191 (UMLS CUI [4,2])
C0009450 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
Allergic Reaction epothilone B | Allergic Reaction docetaxel | Prednisone allergy | Allergic Reaction Compound Similar
Item
allergic reactions to patupilone or docetaxel or prednisone or similar compounds
boolean
C1527304 (UMLS CUI [1,1])
C0297960 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C0246415 (UMLS CUI [2,2])
C0571591 (UMLS CUI [3])
C1527304 (UMLS CUI [4,1])
C1706082 (UMLS CUI [4,2])
C2348205 (UMLS CUI [4,3])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])